1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. MODERNA INC
Moderna Inc XNAS: MRNA

Moderna Inc Live Stock Price Today, Share Analysis and Chart

Weak Stock
about

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. ...

Read More
24.09 -0.38 (-1.55%)
Near 52W Low of $23.15
8.2M
XNAS Volume

XNAS 29 Aug, 2025 4:19 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Moderna Inc is on 08 Sep 2025 for the purpose of Morgan Stanley's 23rd Annual Global Healthcare Conference See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
24.3 / 100
Momentum Score
Technically Bearish
30.4 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
45
1Yr Price target upside is 89%
20 analysts

5

S

20

W

1

O

3

T

SWOT Analysis

Moderna Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..